These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

331 related articles for article (PubMed ID: 2464055)

  • 1. Glyburide blocks the relaxation response to BRL 34915 (cromakalim), minoxidil sulfate and diazoxide in vascular smooth muscle.
    Winquist RJ; Heaney LA; Wallace AA; Baskin EP; Stein RB; Garcia ML; Kaczorowski GJ
    J Pharmacol Exp Ther; 1989 Jan; 248(1):149-56. PubMed ID: 2464055
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The action of diazoxide and minoxidil sulphate on rat blood vessels: a comparison with cromakalim.
    Newgreen DT; Bray KM; McHarg AD; Weston AH; Duty S; Brown BS; Kay PB; Edwards G; Longmore J; Southerton JS
    Br J Pharmacol; 1990 Jul; 100(3):605-13. PubMed ID: 2167738
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potassium channel inhibitors attenuate neuromodulatory effects of atrial natriuretic factor in the rabbit isolated vas deferens.
    Kanwal S; Trachte GJ
    J Pharmacol Exp Ther; 1994 Jan; 268(1):117-23. PubMed ID: 7507992
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alterations by glyburide of effects of BRL 34915 and P 1060 on contraction, 86Rb efflux and the maxi-K+ channel in rat portal vein.
    Hu SL; Kim HS; Okolie P; Weiss GB
    J Pharmacol Exp Ther; 1990 May; 253(2):771-7. PubMed ID: 2110977
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vascular pharmacology of ATP-sensitive K+ channels: interactions between glyburide and K+ channel openers.
    Meisheri KD; Khan SA; Martin JL
    J Vasc Res; 1993; 30(1):2-12. PubMed ID: 8435468
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Some degree of overlap exists between the K(+)-channels opened by cromakalim and those opened by minoxidil sulphate in rat isolated aorta.
    Bray K; Quast U
    Naunyn Schmiedebergs Arch Pharmacol; 1991 Sep; 344(3):351-9. PubMed ID: 1961260
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synergistic effects of glyburide and U-37883A, two structurally different vascular ATP-sensitive potassium channel antagonists.
    Ohrnberger CE; Khan SA; Meisheri KD
    J Pharmacol Exp Ther; 1993 Oct; 267(1):25-30. PubMed ID: 8229751
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of putative activators of K+ channels in mouse pancreatic beta-cells.
    Garrino MG; Plant TD; Henquin JC
    Br J Pharmacol; 1989 Nov; 98(3):957-65. PubMed ID: 2531623
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro and in vivo comparison of two K+ channel openers, diazoxide and cromakalim, and their inhibition by glibenclamide.
    Quast U; Cook NS
    J Pharmacol Exp Ther; 1989 Jul; 250(1):261-71. PubMed ID: 2501478
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of putative K+ channel activator BRL-34915 on arterial contraction and 86Rb efflux.
    Cox RH
    J Pharmacol Exp Ther; 1990 Jan; 252(1):51-9. PubMed ID: 2299602
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of K+ channel blockers and cromakalim (BRL 34915) on the mechanical activity of guinea pig detrusor smooth muscle.
    Grant TL; Zuzack JS
    J Pharmacol Exp Ther; 1991 Dec; 259(3):1158-64. PubMed ID: 1722252
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential inhibition by tedisamil (KC 8857) and glibenclamide of the responses to cromakalim and minoxidil sulphate in rat isolated aorta.
    Bray K; Quast U
    Naunyn Schmiedebergs Arch Pharmacol; 1992 Feb; 345(2):244-50. PubMed ID: 1570027
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glyburide-sensitive K+ channels in cultured rat hippocampal neurons: activation by cromakalim and energy-depleting conditions.
    Politi DM; Rogawski MA
    Mol Pharmacol; 1991 Aug; 40(2):308-15. PubMed ID: 1715018
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of the actions of acetylcholine and BRL 38227 in the guinea-pig coronary artery.
    Eckman DM; Frankovich JD; Keef KD
    Br J Pharmacol; 1992 May; 106(1):9-16. PubMed ID: 1504734
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selective inhibition of relaxation of guinea-pig trachea by charybdotoxin, a potent Ca(++)-activated K+ channel inhibitor.
    Jones TR; Charette L; Garcia ML; Kaczorowski GJ
    J Pharmacol Exp Ther; 1990 Nov; 255(2):697-706. PubMed ID: 1700817
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A sensitive in vitro functional assay to detect K(+)-channel-dependent vasodilators.
    Meisheri KD; Dubray LA; Oleynek JJ
    J Pharmacol Methods; 1990 Dec; 24(4):251-61. PubMed ID: 2292878
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacology and structure-activity relationships for KATP modulators: tissue-selective KATP openers.
    Atwal KS
    J Cardiovasc Pharmacol; 1994; 24 Suppl 4():S12-7. PubMed ID: 7898103
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of cromakalim, RP49356, diazoxide, glibenclamide and galanin in rat portal vein.
    Longmore J; Newgreen DT; Weston AH
    Eur J Pharmacol; 1990 Nov; 190(1-2):75-84. PubMed ID: 1706274
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potassium channel antagonists and vascular reactivity in stroke-prone spontaneously hypertensive rats.
    Kolias TJ; Chai S; Webb RC
    Am J Hypertens; 1993 Jun; 6(6 Pt 1):528-33. PubMed ID: 8343237
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dissociation of actions of BRL 34915 in the rat portal vein.
    Shetty SS; Weiss GB
    Eur J Pharmacol; 1987 Sep; 141(3):485-8. PubMed ID: 3666042
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.